Stay updated on LDX Safety in Children & Adolescents Clinical Trial
Sign up to get notified when there's something new on the LDX Safety in Children & Adolescents Clinical Trial page.

Latest updates to the LDX Safety in Children & Adolescents Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2; the page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA sitewide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” while the study page remains a 403 error. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. This replaces the previously accessible study details with a generic error page.SummaryDifference18%

- Check56 days agoChange DetectedThe page shows a revision bump from v3.6.6 to v3.7.0, indicating a platform update. No changes to the study details or core content are introduced.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision label updated to v3.6.6, replacing v3.6.5. This reflects a minor update to the page version rather than a change to visible content.SummaryDifference0.0%

Stay in the know with updates to LDX Safety in Children & Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LDX Safety in Children & Adolescents Clinical Trial page.